APA (7th ed.) Citation

Nakamaru, Y., Kakubari, M., Yoshida, K., Akimoto, M., & Kondo, K. (2020). An Open-label, Single-dose Study to Evaluate the Pharmacokinetic Variables of Edaravone in Subjects with Mild, Moderate, or No Renal Impairment. Clinical therapeutics, 42(9), 1699-1714. https://doi.org/10.1016/j.clinthera.2020.06.020

Chicago Style (17th ed.) Citation

Nakamaru, Yoshinobu, Masae Kakubari, Kaori Yoshida, Makoto Akimoto, and Kazuoki Kondo. "An Open-label, Single-dose Study to Evaluate the Pharmacokinetic Variables of Edaravone in Subjects with Mild, Moderate, or No Renal Impairment." Clinical Therapeutics 42, no. 9 (2020): 1699-1714. https://doi.org/10.1016/j.clinthera.2020.06.020.

MLA (9th ed.) Citation

Nakamaru, Yoshinobu, et al. "An Open-label, Single-dose Study to Evaluate the Pharmacokinetic Variables of Edaravone in Subjects with Mild, Moderate, or No Renal Impairment." Clinical Therapeutics, vol. 42, no. 9, 2020, pp. 1699-1714, https://doi.org/10.1016/j.clinthera.2020.06.020.